St. Jude Medical (SJM; St. Paul, Minnesota), already a power in a variety of cardiovascular sectors, has entered the stented tissue valve market with the FDA approval last month of its Biocor and Biocor Supra family of stented tissue valves, its first offerings in that market sector in the U.S.